GE Aerospace will buy CPP for $11.75 billion to lock essential turbine blade casting capacity amid persistent bottlenecks and ~30% demand growth by 2030. Musk's SpaceX in-house blade plan has pressured incumbents like Howmet, increasing competitive scrutiny. GE will continue external sourcing, but the deal signals a capacity-expansion strategy with potential long-term margin benefits.
GE Aerospace announced a $12 billion acquisition of Consolidated Precision Products to address shortages of precision jet engine parts and gain access to critical casting technology. The move strengthens vertical integration within GE's aerospace supply chain, potentially improving production resilience and long-term margin stability, though integration risks and financing considerations could weigh on near-term metrics.
GE Aerospace announced it will acquire CPP, a castings maker, from Warburg Pincus and Berkshire Partners for $11.75 billion to strengthen its supply-chain resilience for aerospace components. The deal signals a strategic push to reduce sourcing risk and secure critical parts, potentially improving production throughput but raising near-term cash outlay and integration considerations.
Nelson Peltz's Trian Fund Management boosted its GE HealthCare stake in Q2 while maintaining its GE Aerospace position. The move signals activist oversight across GE's successor firms and could pressure governance and capital-allocation decisions to unlock value in healthcare and aerospace amid macro headwinds.
GE Aerospace reports the GEnx-1B surpassed 50 million flight hours in just over 14 years, the fastest pace for its commercial engines. It serves 50+ operators with about 600,000 flight hours monthly and 99.98% dispatch reliability. GE plans a $1 billion U.S. capex this year to expand production and strengthen the supply chain.
RBC Capital Markets expects GE Aerospace to raise its 2026 EBIT guidance by about $0.5 billion, underpinned by 19% services growth in Q2 and strong aftermarket spending. While the near-term catalyst could boost sentiment, investors should weigh potential 2027 headwinds from tougher comps and ongoing supply-chain tightness, even as LEAP deliveries remain on track.